- Email: [email protected]
ExxonMobil and Shaw in jv
F O C U S are competitive and has joined up with Genencor to develop a bio-based route. Chemical Week, 9 Apr 2003, 165 (13), 16
O N
C ATA LY S T S
Corporation for high pressure hydrogenation and transfer hydrogenation catalysts for making chiral drug intermediates. Chemical Week, 30 Apr 2003, 165 (16), 22
Diversa signs biocatalysis deal with DuPont A 6-year alliance has been agreed between Diversa and DuPont covering the development of biocatalysts for the production of fuel ethanol, 1,3-propanediol and other chemicals from renewable resources. Research funding, milestone payments, and royalties on any new products are to be received by Diversa from DuPont. A consortium that includes both DuPont and Diversa has received $19 M in matching funds from the Department of Energy to develop a refinery for making chemicals from biomass. Chemical Week, 7 May 2003, 165 (17), 7
Dow and Symyx develop new LDPE catalyst Dow Chemical Co and Symyx Technologies Inc have come up with a new class of single-site catalysts for olefins polymerization by applying fully-integrated high-throughput screening methodology. The new amide-ether based hafnium catalyst speeds up the discovery and commercialization of next generation catalysts for olefins polymerization. Symyx has also agreed a multiyear strategic R&D deal with Univation Technologies LLC to discover new and better polymer catalysts for Univation’s PE licensing business. Chemical Market Reporter, 7 Apr 2003 (Website: http://www.chemicalmarketreporter.com) & Chemistry and Industry (London), 7 Apr 2003, (7), 6 & Chemical and Engineering News, 7 Apr 2003, 81 (14), 10
Dowpharma offers chiral hydroformylation catalysts Dowpharma has used technology derived from Union Carbide in 2001 to produce rhodium-based catalysts for chiral hydroformylation. The process is useful for making chiral aldehydes used as intermediates in drug manufacture. Dow pharma has also extended its licensing agreement with the Japanese Science and Technology
JUNE 2003
Eastman: seeking steady growth Eastman Chemical is to develop its custom chemical business, including pharmaceutical intermediates. The company is committed to custom fine chemicals for the long-term. The custom unit supplies markets ranging from drug intermediates and agrochemicals to imaging chemicals and other custom materials. Equal emphasis is being placed on all fine chemicals segments. There is cGMP pilot and commercial production at Llangefni, UK, and commercial cGMP production at Batesville, AR. The company has developed a range of chiral ligands to boost its portfolio for asymmetric catalysis. The latest products are its BoPhoz ligands, which give access to the next generation of catalysts with enantioselectivity for amino acid derivatives by asymmetric hydrogenation. Eastman has also developed new compounds based on epoxybutene. This can be used to make dozens of chiral and achiral products for the drug sector. Chemical Week, 9 Apr 2003, 165 (13), 41
Engelhard’s new FCC catalyst boosts gasoline yields Engelhard Corp has reported the commercialization of its new catalyst Flex-Tec intended for fluid catalytic cracking. This product is claimed to boost gasoline output from resid feedstocks while cutting the production of unwanted heavy fuel oils produced by almost 2000 barrels/day. This new catalyst contains 75 micrometer-dia spheroidal particles with a base-cracking part fabricated of silica alumina. Flex-Tec likewise offers synergistic combination of distributed matrix-structures platform and metals passivation.
Licensing LLC, a 50:50 jv which will license petrochemical technology including ethylbenzene, cumene, styrene, and their derivatives. The firm will also supply catalysts. Stone & Badger acquired Badger Technologies from Washington Group International in Apr 2003 for $17.7 M. Badger’s ethylbenzene and cumene technology is licensed to over 40 sites. ExxonMobil Chemical will also contribute intellectual property and catalyst expertise to the venture. Chemical Market Reporter, 28 Apr 2003 (Website: http://www.chemicalmarketreporter.com) & Chemical Week, 30 Apr 2003, 165 (16), 13
Headwaters Inc announces its subsidiary NanoKinetix Inc has signed an agreement with a major global manufacturer Headwaters Inc announced that its wholly-owned subsidiary, Headwaters NanoKinetix Inc (NanoKinetix) has been engaged by a major global manufacturer to develop engineered nanocatalysts for selective destruction of volatile organic compounds. In addition, NanoKinetix is teaming with its sister business, Covol Fuels, in a related programme supported by a DOE research grant, to develop nanocatalysts to control NOx and SOx generated from coal burning power plants. NanoKinetix has developed a patented nanocatalyst technology, to be marketed under the name NxCat. NxCat technology uses a proprietary process to align, space, and anchor catalytic nanoparticles to commonly used support materials. NanoKinetix expects its novel nanocatalyst technology to provide a strong platform for multiple applications. There are more than $5 trillion worth of products that use catalysts at some point in their manufacture, and many of these products can benefit from NxCat nanocatalyst technology. Headwaters Inc is a world leader in providing technology and services that maximize the value of fossil fuels.
Chemical Engineering Progress, Mar 2003, 99 (3), 15
Press release from: Headwaters Inc, 11778, S Election Road, Suite 210, Draper, UT 84020, USA. Tel: +1 801 984 9400. Fax: +1 801 984 9410. Website: http://www.hdwtrs.com (17 Apr 2003)
ExxonMobil and Shaw in jv
Rentech in another GTL licensing move
ExxonMobil and Stone & Webster (Shaw group) have set up Badger
Rentech of Denver, CO, has forged a licensing deal with Jacobs and
3
O N
C ATA LY S T S
Corporation for high pressure hydrogenation and transfer hydrogenation catalysts for making chiral drug intermediates. Chemical Week, 30 Apr 2003, 165 (16), 22
Diversa signs biocatalysis deal with DuPont A 6-year alliance has been agreed between Diversa and DuPont covering the development of biocatalysts for the production of fuel ethanol, 1,3-propanediol and other chemicals from renewable resources. Research funding, milestone payments, and royalties on any new products are to be received by Diversa from DuPont. A consortium that includes both DuPont and Diversa has received $19 M in matching funds from the Department of Energy to develop a refinery for making chemicals from biomass. Chemical Week, 7 May 2003, 165 (17), 7
Dow and Symyx develop new LDPE catalyst Dow Chemical Co and Symyx Technologies Inc have come up with a new class of single-site catalysts for olefins polymerization by applying fully-integrated high-throughput screening methodology. The new amide-ether based hafnium catalyst speeds up the discovery and commercialization of next generation catalysts for olefins polymerization. Symyx has also agreed a multiyear strategic R&D deal with Univation Technologies LLC to discover new and better polymer catalysts for Univation’s PE licensing business. Chemical Market Reporter, 7 Apr 2003 (Website: http://www.chemicalmarketreporter.com) & Chemistry and Industry (London), 7 Apr 2003, (7), 6 & Chemical and Engineering News, 7 Apr 2003, 81 (14), 10
Dowpharma offers chiral hydroformylation catalysts Dowpharma has used technology derived from Union Carbide in 2001 to produce rhodium-based catalysts for chiral hydroformylation. The process is useful for making chiral aldehydes used as intermediates in drug manufacture. Dow pharma has also extended its licensing agreement with the Japanese Science and Technology
JUNE 2003
Eastman: seeking steady growth Eastman Chemical is to develop its custom chemical business, including pharmaceutical intermediates. The company is committed to custom fine chemicals for the long-term. The custom unit supplies markets ranging from drug intermediates and agrochemicals to imaging chemicals and other custom materials. Equal emphasis is being placed on all fine chemicals segments. There is cGMP pilot and commercial production at Llangefni, UK, and commercial cGMP production at Batesville, AR. The company has developed a range of chiral ligands to boost its portfolio for asymmetric catalysis. The latest products are its BoPhoz ligands, which give access to the next generation of catalysts with enantioselectivity for amino acid derivatives by asymmetric hydrogenation. Eastman has also developed new compounds based on epoxybutene. This can be used to make dozens of chiral and achiral products for the drug sector. Chemical Week, 9 Apr 2003, 165 (13), 41
Engelhard’s new FCC catalyst boosts gasoline yields Engelhard Corp has reported the commercialization of its new catalyst Flex-Tec intended for fluid catalytic cracking. This product is claimed to boost gasoline output from resid feedstocks while cutting the production of unwanted heavy fuel oils produced by almost 2000 barrels/day. This new catalyst contains 75 micrometer-dia spheroidal particles with a base-cracking part fabricated of silica alumina. Flex-Tec likewise offers synergistic combination of distributed matrix-structures platform and metals passivation.
Licensing LLC, a 50:50 jv which will license petrochemical technology including ethylbenzene, cumene, styrene, and their derivatives. The firm will also supply catalysts. Stone & Badger acquired Badger Technologies from Washington Group International in Apr 2003 for $17.7 M. Badger’s ethylbenzene and cumene technology is licensed to over 40 sites. ExxonMobil Chemical will also contribute intellectual property and catalyst expertise to the venture. Chemical Market Reporter, 28 Apr 2003 (Website: http://www.chemicalmarketreporter.com) & Chemical Week, 30 Apr 2003, 165 (16), 13
Headwaters Inc announces its subsidiary NanoKinetix Inc has signed an agreement with a major global manufacturer Headwaters Inc announced that its wholly-owned subsidiary, Headwaters NanoKinetix Inc (NanoKinetix) has been engaged by a major global manufacturer to develop engineered nanocatalysts for selective destruction of volatile organic compounds. In addition, NanoKinetix is teaming with its sister business, Covol Fuels, in a related programme supported by a DOE research grant, to develop nanocatalysts to control NOx and SOx generated from coal burning power plants. NanoKinetix has developed a patented nanocatalyst technology, to be marketed under the name NxCat. NxCat technology uses a proprietary process to align, space, and anchor catalytic nanoparticles to commonly used support materials. NanoKinetix expects its novel nanocatalyst technology to provide a strong platform for multiple applications. There are more than $5 trillion worth of products that use catalysts at some point in their manufacture, and many of these products can benefit from NxCat nanocatalyst technology. Headwaters Inc is a world leader in providing technology and services that maximize the value of fossil fuels.
Chemical Engineering Progress, Mar 2003, 99 (3), 15
Press release from: Headwaters Inc, 11778, S Election Road, Suite 210, Draper, UT 84020, USA. Tel: +1 801 984 9400. Fax: +1 801 984 9410. Website: http://www.hdwtrs.com (17 Apr 2003)
ExxonMobil and Shaw in jv
Rentech in another GTL licensing move
ExxonMobil and Stone & Webster (Shaw group) have set up Badger
Rentech of Denver, CO, has forged a licensing deal with Jacobs and
3